Impact of legislation on nursing home care in the United States: Lessons for the United Kingdom

British Medical Journal

Volumn 319, Issue 7216, 1999, Pages 1060-1063

  Hughes, Carmel M ^a,b   Lapane, Kate L ^a   Mor, Vincent ^a  

^a BROWN UNIVERSITY   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ELDERLY CARE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; LAW; NURSING HOME; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM; UNITED STATES;

AGED; GREAT BRITAIN; HEALTH POLICY; HEALTH SERVICES FOR THE AGED; HUMANS; NURSING HOMES; PRESCRIPTIONS, DRUG; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 0033576181     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (32)

1. 1 Butler RN. Population aging and health. BMJ 1997;315:1082-4.
2. 2 Greengross S, Murphy E, Quam L, Rochon P, Smith R. Aging: a subject that must be at the top of world agendas. BMJ 1997;315:1029-30.
3. 3 Richards T. Ageing costs. BMJ 1998;317:896-900.
4. 4 Ray WA, Federspiel CF, Schaffner W. Study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health 1980;70:485-91.
5. 5 Beers MH, Avorn J, Soumerai SB, Everitt D, Sherman DS, Salem S. Psychoactive medication use in intermediate-care facilities. JAMA 1988;260:3016-20.
6. 6 Avorn J, Dreyer P, Connely K, Soumerai SB. Use of psychoactive medication and the quality of care in rest homes. N Engl J Med 1989;320:227-32.
7. 7 Beardsley RS, Larson DB, Burns BJ, Thompson JW, Kamerow DB. Prescribing of psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989;37:327-30.
8. 8 Stoudemire A, Smith DA. OBRA regulations and the use of psychotropic drugs in long-term care facilities. Impact and implications for geropsychiatric care. Gen Hosp Psychiatry 1996;18:77-94.
9. 9 Institute of Medicine. Improving the quality of care in nursing homes. Washington, DC: National Academy Press, 1986.
10. 10 Elon R, Pawlson LG. The impact of OBRA on medical practices within nursing facilities. J Am Geriatr Soc 1992;40:958-63.
11. 11 Health Care Financing Administration. State operations manual. Baltimore, MA: Health Care Financing Administration, 1995.
12. 12 Tessier EG. Evaluating drug therapy: principles and practices for long-term care providers. In: Tessier EG, Gaziano G, eds. Geriatric drug handbook for long-term care. Baltimore: Williams and Wilkins, 1993;165-74.
13. 13 Challis D, Carpenter I, Traske K. Assesment in continuing care homes: towards a national standard instrument. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury, 1996.
14. 14 Hawes C, Morris JN, Phillips CD, Fries BE, Murphy K, Mor V. Development of the nursing home resident assessment instrument in the USA. Age Ageing 1997;26(suppl 2):19-25.
15. 15 Streim J. OBRA regulations and psychiatric care in the nursing home. Psychiatr Ann 1995;25:413-8.
16. 16 Llorente MD, Olsen EJ, Leyva O, Silverman MA, Lewis JE, Rivero J. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. Am J Geriatr Soc 1998;46:198-201.
17. 17 Morris J, Hawes C, Fries B, Phillips C, Mor V, Katz, S. Designing the national resident assessment system for nursing homes. Gerontologist 1990;30:293-307.
18. 18 Rovner BW, Edelman BA, Cox MP, Schmuely Y. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992;149:1390-2.
19. 19 Semla TP, Palla K, Poddig B, Brauner DJ. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1944;42:648-52.
20. 20 Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994;271:358-62.
21. 21 McGrath AM, Jackson GA. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996;312:611-2.
22. 22 Oborne CA, Li KC, Jackson SHD. How appropriate is neuroleptic prescribing in UK nursing homes? Pharm J 1998;261:R59.
23. 23 Misuse of Drugs Act 1971. London: HMSO, 1971.
24. 24 Deileh R. The limited list of NHS drugs and its effect on their price. Lancet 1985;i:1113.
25. 25 Irwin WG, Mills KA, Steele K. Effect on prescribing of the limited list in a computerised group practice. BMJ 1986;293:857-9.
26. 26 Kane RL, Garrard J. Changing physician prescribing pratices. JAMA 1994;271:393-4.
27. 27 Avorn JL. The elderly and drug policy: coming of age. Health Affairs 1990;9:6-19.
28. 28 Smith DA. New rules for prescribing psychotropics in nursing homes. Geriatrics 1990;45:44-56.
29. 29 Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992;327:168-73.
30. 30 Ray WA, Taylor JA, Meador KG, Lichtenstein MJ, Griffin MR, Fought R, et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med 1993;153:713-21.
31. 31 Royal College of Physicians. Medication for older people. 2nd ed. London: Royal College of Physicians, 1997.
32. 32 Turrell AR, Castleden CM, Freestone B. Long stay care and the NHS: discontinues between policy and practice. BMJ 1998;317:942-4.